This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide Synthesis ...
The expansion will more than double the existing SPPS reactor capacity at CordenPharma Colorado ... end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results